XML 15 R2.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net product revenue $ 77,467 $ 50,025 $ 198,107 $ 118,707
Cost of products sold (4,116)      
Cost of products sold   6,155 7,827 10,465
Gross profit 81,583 43,870 190,280 108,242
Operating expenses:        
Research and development expenses 27,010 3,803 35,619 10,922
Selling, general and administrative expenses 52,636 40,394 146,841 136,422
Total operating expense 79,646 44,197 182,460 147,344
Operating income (loss) 1,937 (327) 7,820 (39,102)
Investment and other income, net 532 610 895 3,114
Interest expense (2,415) (2,820) (7,008) (8,128)
Income (loss) before income taxes 54 (2,537) 1,707 (44,116)
Income tax provision (benefit) 34 88 (3,058) (327)
Net income (loss) $ 20 $ (2,625) $ 4,765 $ (43,789)
Net income (loss) per share  - basic (in dollars per share) $ 0.00 $ (0.03) $ 0.05 $ (0.46)
Net income (loss) per share  - diluted (in dollars per share) $ 0.00 $ (0.03) $ 0.05 $ (0.46)
Weighted average number of shares outstanding - basic (in shares) 97,104 96,300 96,812 94,720
Weighted average number of shares outstanding - diluted (in shares) 101,276 96,300 99,830 94,720